Anti-F11 Neutralizing Antibody (V3S-0622-YC1556) (CAT#: V3S-0622-YC1556)

Send Inquiry
  • fig1
    Figure 1 Anti-F11 Monoclonal Antibody (V3S-0622-YC1556) in SDS-PAGE
  • fig1
    Figure 2 Anti-F11 Monoclonal Antibody (V3S-0622-YC1556) in SEC-HPLC
  • fig1
    Figure 3 Anti-F11 Monoclonal Antibody (V3S-0622-YC1556) in ELISA

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a human monoclonal antibody that reacts with F11. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation.
Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free.
Clonality Monoclonal
Host Species Human
Target Species Human
Isotype IgG

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and/or SEC-HPLC
Endotoxin <1 EU/mg, determined by LAL method
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C.

Applications

Application Inhib; ELISA; FC
Application Notes The antibody is recommended for detection of F11 by Inhib, ELISA, FC assays.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target F11
Alternative Name FXI; F11; coagulation factor XI
Gene ID 2160
UniProt P03951
Related pathway Blood coagulation pathway
Research Area Cardiovascular

Tested Data

SDS-PAGE

Figure 1 Anti-F11 Monoclonal Antibody (V3S-0622-YC1556) in SDS-PAGE

SDS-PAGE analysis of V3S-0622-YC1556 in non-reduced (Lane 1) and β-mercaptoethanol-reduced (Lane 2) conditions. Gel stained for 30 minutes with Coomassie Blue. As a result of different β-mercaptoethanol-reduced proteins (Heavy chain and Light chain) migrate as about 50 kDa and 25 kDa, respectively. And non-reduced protein migrates as 130-180 kDa.

Figure 1 Anti-F11 Monoclonal Antibody (V3S-0622-YC1556) in SDS-PAGE

SEC-HPLC

Figure 2 Anti-F11 Monoclonal Antibody (V3S-0622-YC1556) in SEC-HPLC

The purity of V3S-0622-YC1556 was greater than 95% as determined by SEC-HPLC.

Column: 3 µm, 7.8 x 300 nm
Mobile phase: 150 mM Sodium Phosphate Buffer, pH 7.0
Detection: UV 280 nm
Injection: 10 µl

Figure 2 Anti-F11 Monoclonal Antibody (V3S-0622-YC1556) in SEC-HPLC

ELISA

Figure 3 Anti-F11 Monoclonal Antibody (V3S-0622-YC1556) in ELISA

ELISA analysis of V3S-0622-YC1556 was performed by coating with human F11, His Tag (1 µg/ml). Then blocked with BSA and incubated with V3S-0622-YC1556. The HRP-conjugated goat anti-human IgG as a secondary antibody. Detection was performed using TMB substrate and stopped with sulfuric acid. The absorbances were read on a spectrophotometer at 450 nm.

Figure 3 Anti-F11 Monoclonal Antibody (V3S-0622-YC1556) in ELISA

For research use only, not directly for clinical use.
banner banner
© 2025 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry